Wassilew S W, Koch I
Arch Dermatol Res. 1978 Aug 28;262(3):267-74. doi: 10.1007/BF00447363.
The in vivo stimulation of lymphocytes was used to assess cell mediated immunity to herpes simplex virus (hsv) in patients with recurrent skin eruptions caused by this virus. 1. Phytohaemagglutinine stimulation of lymphocytes was normal in all examined patients. There was no difference in the PHA-stimulation of a control group. 2. Specific lymphocytes stimulation by hsv-antigen may be regarded as a sensitive parameter for a previous hsv-infection. 3. In 6 patients with severe infections of hsv type I or II and more than 10 recurrences per year we found a lower stimulation than in patients with occasionally (up to 10 times a year) skin eruptions. 4. An antigen used as vaccine, Lupidon H, ten times more concentrated (100,000 EID/ml) than the commercially available antigen is able to stimulate lymphocytes in vitro.
采用体内刺激淋巴细胞的方法,评估由单纯疱疹病毒(HSV)引起复发性皮肤疹患者的细胞介导免疫。1. 所有受检患者淋巴细胞的植物血凝素刺激均正常。对照组的PHA刺激无差异。2. HSV抗原对特异性淋巴细胞的刺激可被视为既往HSV感染的敏感参数。3. 在6例患有严重I型或II型HSV感染且每年复发超过10次的患者中,我们发现其刺激程度低于偶尔(每年最多10次)出现皮肤疹的患者。4. 一种用作疫苗的抗原Lupidon H,其浓度比市售抗原高10倍(100,000 EID/ml),能够在体外刺激淋巴细胞。